GlaxoSmithKline Pakistan Market Cap

GlaxoSmithKline Pakistan has a market cap or net worth of 132.53 billion as of April 4, 2025. Its market cap has increased by 379.45% in one year.

Market Cap

132.53B

Enterprise Value

126.19B

Revenue

61.19B

Ranking

n/a

PE Ratio

20.28

Stock Price

416.16

Market Cap Chart

Since September 26, 1994, GlaxoSmithKline Pakistan's market cap has increased from 3.77B to 132.53B, an increase of 3,414.68%. That is a compound annual growth rate of 12.36%.

Market Cap History

Date	Market Cap	% Change
Apr 3, 2025	133.31B	5.46%
Dec 31, 2024	126.40B	378.26%
Dec 29, 2023	26.43B	-5.45%
Dec 30, 2022	27.95B	-35.70%
Dec 31, 2021	43.47B	-28.84%
Dec 31, 2020	61.09B	19.47%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Abbott Laboratories (Pakistan)	107.15B
AGP Limited	53.23B
The Searle Company	50.52B
Highnoon Laboratories	48.62B
Shifa International Hospitals	30.35B
Citi Pharma	20.97B
Ferozsons Laboratories	13.66B
Otsuka Pakistan	2.19B

Market Cap Rankings